AAL
51
-6
BIIB
48
2
ADT
50
2
VRSK
30
-39
LEN
36
-5
NOC
51
-3
TEL
58
-24
TMO
56
-11
PSA
46
-18
UNP
39
-19
IFF
56
3
EQT
51
4
MPC
39
-2
V
50
-26
STT
60
-14
SE
41
-38
GILD
50
3
OXY
38
5
PCG
70
-10
PCAR
62
-6
AAL
51
-6
BIIB
48
2
ADT
50
2
VRSK
30
-39
LEN
36
-5
NOC
51
-3
TEL
58
-24
TMO
56
-11
PSA
46
-18
UNP
39
-19
IFF
56
3
EQT
51
4
MPC
39
-2
V
50
-26
STT
60
-14
SE
41
-38
GILD
50
3
OXY
38
5
PCG
70
-10
PCAR
62
-6
Financhill
Back

RBC Short Term U.S. Corporate Bond ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
30

RUSB.TO
RBC Short Term U.S. Corporate Bond ETF

Last Price:
$21.62
Seasonality Move:
0.62%
Buy
57

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$82.65
Seasonality Move:
-32.16%
Sell
30
RBC Short Term U.S. Corporate Bond ETF (RUSB.TO) is a Sell

Is RBC Short Term U.S. Corporate Bond ETF a Buy, Sell or Hold?

  • The current RBC Short Term U.S. Corporate Bond ETF [RUSB.TO] share price is $21.69. The Score for RUSB.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RUSB.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RUSB.TO Stock Price Chart

What is RBC Short Term U.S. Corporate Bond ETF's stock price today?

  • The RBC Short Term U.S. Corporate Bond ETF share price today is $21.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RUSB.TO is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

RUSB.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.73 Buy
Relative Strength Index (14 RSI): 35.17 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.73 - 22.11) Sell
Bollinger Bands (100): (21.63 - 22.05) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.77 Buy
Relative Strength Index (14 RSI): 66.44 Buy
Chaikin Money Flow: -23974 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.51 - 82.89) Buy
Bollinger Bands (100): (41.26 - 68.88) Buy

RUSB.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.68 Buy
20-day SMA: 21.89 Sell
50-day SMA: 21.99 Sell
200-day SMA: 21.71 Sell
8-day EMA: 4.82 Buy
20-day EMA: 2.07 Buy
50-day EMA: 0.85 Buy
200-day EMA: 0.22 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.48 Buy
20-day SMA: 74.4 Buy
50-day SMA: 65.57 Buy
200-day SMA: 42.82 Buy
8-day EMA: 85.2 Buy
20-day EMA: 77.09 Buy
50-day EMA: 66.93 Buy
200-day EMA: 47.3 Buy

RBC Short Term U.S. Corporate Bond ETF Earnings Growth & RUSB.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

RBC Short Term U.S. Corporate Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):